Literature DB >> 21643959

Impact of DNA repair genes polymorphism (XPD and XRCC1) on the risk of breast cancer in Egyptian female patients.

Yousry Mostafa Hussien1, Amal F Gharib, Hanan A Awad, Rehab A Karam, Wael H Elsawy.   

Abstract

The genes involved in DNA repair system play a crucial role in the protection against mutations. It has been hypothesized that functional deficiencies in highly conserved DNA repair processes resulting from polymorphic variation may increase genetic susceptibility to breast cancer (BC). The aim of the present study was to evaluate the association of genetic polymorphisms in 2 DNA repair genes, XPD (Asp312Asn) and XRCC1 (A399G), with BC susceptibility. We further investigated the potential combined effect of these DNA repair variants on BC risk. Both XPD (xeroderma pigmentosum group D) and XRCC1 (X-ray repair cross-complementing group 1) polymorphisms were characterized in 100 BC Egyptian females and 100 healthy women who had no history of any malignancy by amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) method and PCR with confronting two-pair primers (PCR-CTPP), using DNA from peripheral blood in a case control study. Our results revealed that the frequencies of AA genotype of XPD codon 312 polymorphism were significantly higher in the BC patients than in the normal individuals (P ≤ 0.003), and did not observe any association between the XRCC1 Arg399Gln polymorphism and risk of developing BC. Also, no association between both XPD Asp312Asn and XRCC1 A399G polymorphisms and the clinical characteristics of disease. Finally, the combination of AA(XPD) + AG(XRCC1) were significantly associated with BC risk. Our results suggested that, XPD gene is an important candidate gene for susceptibility to BC. Also, gene-gene interaction between XPD(AA) + XRCC1(AG) polymorphism may be associated with increased risk of BC in Egyptian women.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643959     DOI: 10.1007/s11033-011-0935-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  39 in total

1.  XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency.

Authors:  R M Lunn; R G Langlois; L L Hsieh; C L Thompson; D A Bell
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

2.  DNA repair proficiency: potential susceptiblity factor for breast cancer.

Authors:  K J Helzlsouer; E L Harris; R Parshad; H R Perry; F M Price; K K Sanford
Journal:  J Natl Cancer Inst       Date:  1996-06-05       Impact factor: 13.506

3.  XPD common variants and their association with melanoma and breast cancer risk.

Authors:  T Debniak; R J Scott; T Huzarski; T Byrski; B Masojć; T van de Wetering; P Serrano-Fernandez; B Górski; C Cybulski; J Gronwald; B Debniak; R Maleszka; J Kładny; A Bieniek; L Nagay; O Haus; E Grzybowska; P Wandzel; S Niepsuj; S A Narod; J Lubinski
Journal:  Breast Cancer Res Treat       Date:  2006-05-10       Impact factor: 4.872

4.  A prediction model for the incidence patterns of female breast cancers in Alexandria, Egypt.

Authors:  Gihan Hosny; Saleh M Elkaffas
Journal:  J Egypt Public Health Assoc       Date:  2002

5.  Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer.

Authors:  Priya Chacko; Balakrishnan Rajan; Thomas Joseph; Beela Sarah Mathew; M Radhakrishna Pillai
Journal:  Breast Cancer Res Treat       Date:  2005-01       Impact factor: 4.872

6.  Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients.

Authors:  Ugur Deligezer; Nejat Dalay
Journal:  Exp Mol Med       Date:  2004-12-31       Impact factor: 8.718

7.  Common XPD (ERCC2) polymorphisms have no measurable effect on nucleotide excision repair and basal transcription.

Authors:  Jean Philippe Lainé; Vincent Mocquet; Marion Bonfanti; Cathy Braun; Jean Marc Egly; Pierre Brousset
Journal:  DNA Repair (Amst)       Date:  2007-04-02

8.  DNA repair proficiency: a potential marker for identification of high risk members in breast cancer families.

Authors:  B Jyothish; R Ankathil; R Chandini; B Vinodkumar; G S Nayar; D D Roy; J Madhavan; M K Nair
Journal:  Cancer Lett       Date:  1998-02-13       Impact factor: 8.679

9.  Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) polymorphisms in familial and sporadic breast cancer predisposition and survival: an Indian report.

Authors:  Volga S Syamala; Vani Syamala; Hariharan Sreedharan; Praveenkumar B Raveendran; Ratheesan Kuttan; Ravindran Ankathil
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

Review 10.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

View more
  13 in total

1.  Association between DNA repair genes (XPD and XRCC1) polymorphisms and susceptibility to age-related cataract (ARC): a meta-analysis.

Authors:  Lie-rui Zheng; Jian-jun Ma; Dang-xia Zhou; Li-feng An; Ya-qing Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-07       Impact factor: 3.117

2.  Three polymorphisms of DNA repair gene XRCC1 and the risk of glioma: a case-control study in northwest China.

Authors:  Gaofeng Xu; Maode Wang; Wanfu Xie; Xiaobin Bai
Journal:  Tumour Biol       Date:  2013-09-19

3.  Association analysis between MDR1 genetic variant and breast cancer risk factors in Chinese Han population.

Authors:  Yi Hu; Jingliang Wang; Haitao Tao; Huan Wang; Xin Zhang; Yao Cheng; Ruixin Li
Journal:  Med Oncol       Date:  2013-08-08       Impact factor: 3.064

4.  The influence of genetic polymorphisms in MDR1 gene on breast cancer risk factors in Chinese.

Authors:  Yunhe Jia; Wenjing Tian; Shuai Sun; Peng Han; Weinan Xue; Mingqi Li; Yanlong Liu; Shixiong Jiang; Binbin Cui
Journal:  Med Oncol       Date:  2013-05-21       Impact factor: 3.064

5.  Investigation on XRCC1 genetic polymorphism and its relationship with breast cancer risk factors in Chinese women.

Authors:  Luming Zheng; Feng Yang; Xukui Zhang; Jian Zhu; Pen Zhou; Fang Yu; Lei Hou; Guowei Zhao; Qingqing He; Baocheng Wang
Journal:  Med Oncol       Date:  2013-10-25       Impact factor: 3.064

6.  XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis.

Authors:  Yulan Yan; Hongjie Liang; Morning Light; Taijie Li; Yan Deng; Meng Li; Shan Li; Xue Qin
Journal:  Tumour Biol       Date:  2013-10-08

Review 7.  XRCC1 and OGG1 Gene Polymorphisms and Breast Cancer: A Systematic Review of Literature.

Authors:  Ali Sanjari Moghaddam; Milad Nazarzadeh; Rezvan Noroozi; Hossein Darvish; Alireza Mosavi Jarrahi
Journal:  Iran J Cancer Prev       Date:  2016-02-23

Review 8.  Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.

Authors:  Feifan Xiao; Jian Pu; Qiongxian Wen; Qin Huang; Qinle Zhang; Birong Huang; Shanshan Huang; Aihua Lan; Yuening Zhang; Jiatong Li; Dong Zhao; Jing Shen; Huayu Wu; Yan He; Hongtao Li; Xiaoli Yang
Journal:  Oncotarget       Date:  2017-07-18

9.  Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.

Authors:  Zoi Lanara; Efstathia Giannopoulou; Marta Fullen; Evangelos Kostantinopoulos; Jean-Christophe Nebel; Haralabos P Kalofonos; George P Patrinos; Cristiana Pavlidis
Journal:  Hum Genomics       Date:  2013-06-05       Impact factor: 4.639

10.  Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.

Authors:  Hanaa Hardi; Rahma Melki; Zouhour Boughaleb; Tijani El Harroudi; Souria Aissaoui; Noureddine Boukhatem
Journal:  BMC Cancer       Date:  2018-03-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.